Government writes to DoP to repeal three pharmaceuticals Acts

Published On 2016-11-15 09:29 GMT   |   Update On 2016-11-15 09:29 GMT
New Delhi: Three Acts governing the pharmacetuical industry, in all likelihood are expected to be repealed, as the government has written to the department of Pharmaceuticals (DoP) to review these three pharmaceutical acts and introduce a bill to repeal them.

The pharmaceutical acts in question include Pharmacy (Amendment) Act, 1959 (24 of 1959), the National Institute of Pharmaceutical Educational and Research (Amendment) Act, 2002 (28 of 2002), and the National Institute of Pharmaceutical Educational and Research (Amendment) Act, 2007 (19 of 2007), reports
Live Mint
.

A PMO letter, dated 6th November to the DoP has asked the department to give a review on the act and provide its views on the same. The department has also been asked to prepare the introduction of a bill aiming to repeal the acts.

The PMO letter to the department of pharmaceuticals, government of India read, “(The legislative department is)… seeking your comments/concurrence… to facilitate introduction of a Bill to for repeal of the identified Acts in the next session of Parliament,” the PMO said in the letter.

Response from the department is also called for by the Prime Minister’s office.

This comes after the law commission made recommendations based on the considerations of the legislative department under Ministry of Law and Justice, which is thinking over to take back old laws and acts.The law commission had earlier made recommendations to repeal in total 252 laws over four of its reports, submitted to the PMO from September to November 2014. While the PMO formed two-member committee identified around 1,741 central laws to be repealed, out of total 2,781 governing Acts of various industries.
Article Source : With inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News